Clinical trial
Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein…
NCT00406107 · Palmetto Retina Center, LLC, Other · Completed
Key facts
| NCT number | NCT00406107 |
|---|---|
| Title | Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion |
| Official title | Open Label Macugen for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion |
| Lead sponsor | Palmetto Retina Center, LLC, Other |
| Collaborators | Pfizer Industry Eyetech Pharmaceuticals |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Branch Retinal Vein Occlusion |
| Intervention type | Drug |
| Interventions | pegaptanib sodium (Macugen) |
| Enrollment | 20 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Dec 4, 2006 |
| Last update posted | Sep 12, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: